Interleukin-6 to stimulate erythropoietin production
US5188828A · kind A · utility
16Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 1990 |
| Grant date | Feb 23, 1993 |
| Priority date | — |
| Expiry date | Nov 8, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/204
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to the administration of Interleukin 6 for the purpose of enhancing endogenous erythropoietin levels in vitro and in vivo. The invention further encompasses methods of treatment of disorders characterized by, or including, erythropoietin deficiency. Such disorders include the anemias of chronic inflammation, renal failure, AIDS, and malignancy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.